Last week we held our latest Women In Biotech event in central London. We were lucky enough to have two thought-provoking talks from our guest speakers Professor Melissa Hanna Brown from Pfizer, and Dr Emma Sceats from CN Bio, who gave us their insights into the role of women as both intrapreneurs and entrepreneurs in the life sciences. A big thank you to Bristows LLP for hosting.
This week the BIA held a member webinar entitled ‘Funding and solving R&D challenges: scientific, commercial and animal welfare drivers behind NC3Rs and CRACK IT Challenges’, which presented a fascinating case study of innovative collaboration from the CRACK IT project.
I was thrilled to see the launch of our new website go so smoothly last week, and I’d encourage everyone to take a look and familiarise yourself with some of the new functionality. One of the most useful functions is the ability for members to upload their news and job vacancies directly to our site, for the BIA team to approve and publish. Do take the opportunity to raise the profile of your organisation on the new BIA website
This week we are taking a look at one of the most pressing issues facing the world today – the rise of antimicrobial resistance. Many of our member organisations are leading the charge in developing innovative solutions to this challenge, and it is gathering increasing public recognition.
It’s a new term with a new look here at the BIA. Not just a new look Newscast but the BIA’s new website has now gone live. A significant update being cleaner, sleeker, and more user-friendly than our old site, with new member functionality. From next week, members will be able to upload their available job listings and news updates directly to the site for the BIA team to approve and publish, which will be given better profile across the BIA site. Do please familiarise yourself with the new site, and let us know what you think.
The following guest blog is from Sarah Goulding of Innovate UK’s Knowledge Transfer Network (KTN). Sarah explains a new £15m Innovate UK funding competition to drive innovation in medicines manufacturing.
Author – Dr Jon Moore, Chief Scientific Officer and Head of Translational Science, Horizon Discovery
CRISPR made another break out from the technical literature to the popular press this month with a story about mice with skin grafts engineered to express the insulin regulating hormone GLP1.
In this edition:
Further developments in the IP Group and Touchstone Innovations takeover
The start of the critically important Patient Capital Review Consultation
We explain what a NOMAD is
Sphere Medical is our Deal of the Month
Our Investor infoshot is on SV Health Investors
This is the latest update from the Medicines Manufacturing Industry Partnership. If you have any feedback on the content or information here then please email us at MMIP@bioindustry.org. If you have any colleagues you feel would be interested in learning more about the work of MMIP then please ask them to get in touch with us or sign up to our mailing list here.
This week's video is from Understanding Animal Reseach. The blood brain barrier is essential for good health, but prevents many medicines reaching the brain. How do you get past this biological barrier?